UBS Group’s Sanaby Health Acquisition Corp. I Class A Common Stock SANB Stock Holding History

UBS Group’s Portfolio SANB Stock Details SANB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-144	Closed	-$1K	–	11936
2022 Q3	$1K	Buy	144 +50	+53%	+$505	﹤0.01%	10242
2022 Q2	$1K	Sell	94 -900	-91%	-$9.03K	﹤0.01%	10188
2022 Q1	$10K	Buy	+994	New	+$9.9K	﹤0.01%	8501

UBS Group's SANB Position: Q4 2022 in Review

UBS Group sold out of Sanaby Health Acquisition Corp. I Class A Common Stock (SANB) in Q4 2022, closing a stake of 144 shares — an estimated $1K sold.

UBS Group first reported a position in SANB in Q1 2022 and held it in 3 quarters. The position peaked at $10K in Q1 2022. 0 funds tracked by Wall St. Rank hold SANB as of Q4 2022.

UBS Group reported no remaining Sanaby Health Acquisition Corp. I Class A Common Stock position as of Q4 2022 after selling out during the quarter.
UBS Group sold 144 Sanaby Health Acquisition Corp. I Class A Common Stock shares in Q4 2022, an estimated $1K.
UBS Group first reported a position in Sanaby Health Acquisition Corp. I Class A Common Stock in Q1 2022 and held it in 3 quarters.
UBS Group's Sanaby Health Acquisition Corp. I Class A Common Stock position peaked at $10K in Q1 2022.
0 funds tracked by Wall St. Rank held Sanaby Health Acquisition Corp. I Class A Common Stock as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.